INTERMEDIATES
We supply a comprehensive range of pharmaceutical intermediates that serve as vital building blocks in the development and production of Active Pharmaceutical Ingredients (APIs). Our portfolio includes intermediates for various therapeutic segments such as anticoagulants, anti-diabetics, oncology drugs, cardiovascular agents, and nootropics.
All our intermediates are sourced from trusted manufacturers, ensuring high purity, consistency, and regulatory compliance. With a focus on quality and timely delivery, we support pharmaceutical companies across research, pilot-scale, and commercial production requirements.
Pharmaceutical Intermediates
| API NAME | INTERMEDIATE | CAS NO |
| AFATINIB | 4-Chloro-7-fluoro-6-nitroquinazoline | 162012-70-6 |
| AFATINIB | 3-Chloro-4-fluoroaniline | 367-21-5 |
| AFATINIB | (S)-3-Hydroxytetrahydrofuran | 86087-23-2 |
| AFATINIB | N-(3-Chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine | 162012-67-1 |
| AFATINIB | N-(3-Chloro-4-fluorophenyl)-6-nitro-7-[(3S)-tetrahydrofuran -3-yloxy] | 1027407-75-5 |
| ANIRACETAM | 4-Methoxy Benzoic Acid | 100-09-4 |
| ANIRACETAM | 1-(4-Methoxybenzoyl)-2-pyrrolidinone, Aniracetam | 72432-10-1 |
| APIXABAN | Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate | 27143-07-3 |
| APIXABAN | 3-Chloro-5,6-dihydro-1-(4-nitrophenyl)-2(1H)-pyridinone | 536760-29-9 |
| APIXABAN | 3-Morpholin-4-yl-1-[4-(2-oxopiperidin-1-yl)phenyl]-5,6-dihydro1H-pyridin-2-1 | 545445-44-1 |
| APIXABAN | 4,5,6,7-Tetrahydro-5-methylthiazolo[5,4-c]pyridine-2-carboxylic acid hcl | 720720-96-7 |
| ATORVASTATIN | -dimethyl-1,3-dioxane-4-acetate | 289042-12-2 |
| ATORVASTATIN | tert-Butyl (4R,6R)-2-[[[6-(2-4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxan-4-yl]acetate | 125971-95-1 |
| ATORVASTATIN | (4R,6R)-tert-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate | 125995-13-3 |
| ATORVASTATIN | Benzyl (4-hydroxybutyl)carbamate | 17996-13-3 |
| ATORVASTATIN | 3-[(Benzyloxycarbonyl)amino]propionaldehyde | 65564-05-8 |
| ATORVASTATIN | [R-(R*, R*)]-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylaminocarbonyl)-1H-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid calcium salt | 134523-03-8 |
| ATORVASTATIN | Fluorobenzene | 462-06-6 |
| AXITINIB | Xantphos or 4,5-Bis(diphenylphosphino)-9,9-dimethyl xanthene | 161265-03-8 |
| AXITINIB | Tris(o-Tolyl)phosphine or P(o-Tol)3 | 6163-58-2 |
| AXITINIB | 3,4-Dihydro-2H-pyran | 110-87-2 |
| AXITINIB | Di-tert-butyl dicarbonate (BOC-anhydride) | 24424-99-5 |
| BENAZEPRIL | L-Homophenylalanine ethyl ester hydrochloride | 90891-21-7 |
| BENAZEPRIL | 3-Bromo-2,3,4,5-tetrahydro-2H-benzo[b]azepin-2-one | 86499-96-9 |
| BENAZEPRIL | S-ATBA | 109010-60-8 |
| BENAZEPRIL | Ethyl (R)-2-hydroxy-4-phenylbutyrate | 90315-82-5 |
| BENDAMUSTIN HCL | 4-{5-[Bis-(2-hydroxy-ethyl)-amino]-1-methyl-1H-benzoimidazol-2-yl}-butyric acid ethyl ester | 3543-74-6 |
| BENDAMUSTIN HCL | 4-(5-Amino-1-methyl-1H-benzoimidazol-2-yl)-butyric acid ethyl ester | 3543-73-5 |
| BETRIXABAN | 2-Amino-5-chloropyridine | 1072-98-6 |
| BETRIXABAN | (2-amino-N-(5-chloropyridin-2-yl)-5-methoxybenzamide) | 1183836-56-7 |
| BETRIXABAN | 4-Cyanobenzoic acid | 619-65-8 |
| BETRIXABAN | 4-[(Dimethylamino)iminomethyl]benzoic acid monohydrochloride | 210963-78-3 |
| BETRIXABAN | 5-Methoxy-2-nitrobenzoic acid | 1882-69-5 |
| BILASTINE | 2-(4-Bromophenyl)-2-methylpropionic acid | 32454-35-6 |
| BILASTINE | 2-Methyl-2-phenylpropionic acid | 826-55-1 |
| BOSENTAN | 4-tert-Butylbenzenesulfonamide | 6292-59-7 |
| BOSENTAN | 2-Amidinopyrimidine hydrochloride | 138588-40-6 |
| BOSENTAN | 4,6-Dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine | 150728-13-5 |
| BOSENTAN | 5-(2-Methoxyphenoxy)-[2,2'-bipyrimidine]-4,6(1H,5H)-dione | 150728-12-4 |
| BREXIPIPRAZOLE | 7-(4-Chlorobutoxy)-2(1H)-quinolinone | 913613-82-8 |
| BREXIPIPRAZOLE | 1-Benzo[b]thiophene-4-yl-piperazine hydrochloride | 913614-18-3 |
| BREXIPIPRAZOLE | 7-Hydroxyquinolinone | 70500-72-0 |
| BREXIPIPRAZOLE | 4-chloro- Benzo[b]thiophene. | 66490-33-3 |
| BREXIPIPRAZOLE | 4-BROMO-BENZO[B]THIOPHENE | 5118-13-8 |
| BRINZOLAMIDE | Hydroxylamine-O-sulfonic acid | 2950-43-8 |
| BRINZOLAMIDE | (S)-3,4-Dihydro-4-hydroxy-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide | 154127-42-1 |
| BRINZOLAMIDE | 6-Chloro-2,3-dihydro-4H-thieno[3,2-e][1,2]thiazin-4-one 1,1-dioxide | 174139-69-6 |
| BRIVARACETAM | 5-hydroxy-4-propylfuran-2(5H)-one | 78920-10-2 |
| BRIVARACETAM | (4S)-Brivaracetam | 357336-19-7 |
| BRIVARACETAM | (R)-4-PROPYLPYRROLIDIN-2-ONE | 930123-37-8 |
| BRIVARACETAM | 4-propyl-2-Pyrrolidinone | 89895-19-2 |
| BRIVARACETAM | ETHYL 3-(NITROMETHYL)HEXANOATE | 128013-61-6 |
| BRIVARACETAM | Ethyl (E)-hex-2-enoate | 27829-72-7 |
| BRIVARACETAM | (R)-Dihydro-4-propyl-2(3H)-furanone | 63095-51-2 |
| CANAGIFLOZIN | 5-Bromo-2-methylbenzoic acid | 79669-49-1 |
| CANAGIFLOZIN | 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone | 32384-65-9 |
| CANAGIFLOZIN | 2-(4-Fluorophenyl)thiophene | 58861-48-6 |
| CANAGIFLOZIN | 2,3,4,6-Tetra-O-benzyl-D-glucono-1,5-lactone | 13096-62-3 |
| CANAGIFLOZIN | 5-Iodo-2-methylbenzoic acid | 54811-38-0 |
| CANAGIFLOZIN | 4-(5-BROMO-2-CHLOROBENZYL)PHENOL | 864070-18-8 |
| CAPACITABINE | 2',3'-Di-O-Acetyl-5'-Deoxy-5-Fluorocytidine | 161599-46-8 |
| CAPACITABINE | Fluorocytosine | 2022-85-7 |
| CAPACITABINE | D-Ribose | 50-69-1 |
| CAPACITABINE | 2,3-Di-O-acetyl-5-deoxy-5-fuluro-D-cytidine | 161500-46-8 |
| CAPACITABINE | 5'-Deoxy-5-fluorocytidine | 66335-38-4 |
| CITICOLIN | Cytidine 5'-Monophosphate | 63-37-6 |
| CITICOLIN | N,N′-Dicyclohexylcarbodiimide | 538-75-0 |
| CITICOLIN | cytosine | 71-30-7 |
| CLOPIDOGREL BISULFATE | Thiophene-2-ethanol | 5402-55-1 |
| CLOPIDOGREL BISULFATE | Thiophene-2-ethylamine | 30433-91-1 |
| CLOPIDOGREL BISULFATE | L-(-)-Camphoresulfonic acid | 35963-20-3 |
| CLOPIDOGREL BISULFATE | DL-2-(2-Chlorophenyl)glycine | 141196-64-7 |
| DAPAGIFLOZIN | (5-BroMo-2-chlorophenyl)(4-ethoxyphenyl)Methanone | 461432-22-4 |
| DAPAGIFLOZIN | 5-Bromo-2-chloro-4’-ethoxydiphenylmethane | 461432-23-5 |
| DAPAGIFLOZIN | 2-Chloro-5-nitrobenzoic Acid | 2516-96-3 |
| DAPAGIFLOZIN | 5-Bromo-2-Chloro Benzoic acid | 21739-92-4 |
| DAPAGIFLOZIN | D-Gluconic acid, 2,3,4,6-tetrakis-O-(triMethylsilyl)-, d-lactone | 32384-65-9 |
| DULOXETINE | 1-Fluoronaphthalene | 321-38-0 |
| DULOXETINE | S-(-)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)propanamine | 132335-44-5 |
| DULOXETINE | N,N-Dimethyl-3-hydroxy-3-(2-thienyl)propanamine | 13636-02-7 |
| DULOXETINE | S-(+)-N,N-Dimethyl-3-(1-naphthoxy)-3-(2-thienyl)-1-propylamine oxalate | 132335-47-8 |
| EDOXABAN | 2-[(5-Chloropyridin-2-yl)amino]-2-oxoacetic acid ethyl ester monohydrochloride | 1243308-37-3 |
| EDOXABAN | tert-Butyl(1R,2S,5S)-2-amino-5-(dimethylamino)carbamoyl)cyclohexylcarbamate oxalate monohydrate | 1353893-22-7 |
| EDOXABAN | (3aR,4S,6R,6aS)-6-aminotetrahydro-2,2-dimethyl-4H-Cyclopenta-1,3-dioxol-4-ol | 155899-66-4 |
| EDOXABAN | 2-[[(3aR,4S,6R,6aS)-6-aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]ethanol | 274693-55-9 |
| EDOXABAN | 4,6-dichloro-2-propylthio-pyrimidine-5-amine | 145783-15-9 |
| EDOXABAN | (1R,2S)-2-(3,4-difluorophenyl)- Cyclopropanamine | 220352-38-5 |
| ELTROMBOPAG | 2-Bromo-6-nitrophenol | 13073-25-1 |
| ELTROMBOPAG | 1-Bromo-2-methoxy-3-nitrobenzene | 98775-19-0 |
| ELTROMBOPAG | 3,4-Dimethylphenylhydrazine hydrochloride | 60481-51-8 |
| EMPAGIFLOZIN | (S)-(+)-3-Hydroxytetrahydrofuran | 86087-23-2 |
| EMPAGIFLOZIN | (3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan | 915095-94-2 |
| EMPAGIFLOZIN | 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone | 32384-65-9 |
| EMPAGIFLOZIN | (3S)-Tetrahydro-3-Furanyl 4-Methylbenzenesulfonate | 112052-11-6 |
| EMPAGIFLOZIN | (3R)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran | 915095-90-8 |
| ERTAPENEM | beta-Methyl vinyl phosphate CAS NO. 90776-59- | 90776-59-3 |
| EZETIMIB | (3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-[4-(phenylmethoxy)phenyl]-2-azetidinone | 163222-32-0 |
| EZETIMIB | (4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone | 189028-93-1 |
| EZETIMIB | (3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one | 190595-65-4 |
| EZETIMIB | Methyl (3R,4S)-1-(4-fluorophenyl)-2-oxo-4-[4-(phenylmethoxy)phenyl]-3-azetidinepropanoate | 204589-80-0 |
| EZETIMIB | (R)-2-Methyl-CBS-oxazaborolidine | 112022-83-0 |
| EZETIMIB | 4-(4-Hydroxybenzylidene)Fluoroaniline | 3383-63-6 |
| FAROPENEM | Tetrahydro-2-furancarboxylic acid | 16874-33-2 |
| FAROPENEM | (3R,4R)-4-Acetoxy-3-[(R)-(tert-butyldimethylsilyloxy)ethyl]-2-azetidinone | 76855-69-1 |
| FAROPENEM | S-(-)-a-Methylbenyl amine | 2627-86-3 |
| FAROPENEM | Sodium 2-ethylhexanoate | 19766-89-3 |
| GLICLAZIDE | 3-Amino-3-azabicyclo[3.3.0]octane hydrochloride | 58108-05-7 |
| GLICLAZIDE | 3-Amino-3-azabicyclo[3.3.0]octane | 54528-00-6 |
| GLICLAZIDE | 3-Azabicyclo[3.3.0]octane hydrochloride | 112626-50-3 |
| IGURATIMOD | N-[4-[(Formylamino)acetyl]-5-hydroxy-2-phenoxyphenyl]methanesulfonamide | 149457-03-4 |
| IGURATIMOD | 4-Chloro-3-nitroanisole | 10298-80-3 |
| IGURATIMOD | N-(4-(2-Aminoacetyl)-5-methoxy-2-phenoxyphenyl)methanesulfonamide hydrochloride | 149436-41-9 |
| IGURATIMOD | N-(5-methoxy-2-phenoxyphenyl)methanesulfonamid | 88381-56-7 |
| IMATINIB | N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-Pyrimidineamine | 152460-10-1 |
| LAPATINIB | 4-Chloro-7-methoxy-quinoline-6-carboxylic acid amide | 417721-36-9 |
| LAPATINIB | 4-Amino-3-chlorophenol hydrochloride | 52671-64-4 |
| LAPATINIB | 4-(3-fluorobenzyloxy)-3-chlorobenzenamine | 202197-26-0 |
| LAPATINIB | 4-chloro-6-iodoquinazoline | 98556-31-1 |
| LEFLUNOMIDE | 5-Methylisoxazole-4-carboxylic Acid | 42831-50-5 |
| LEFLUNOMIDE | 2-Bromo-5-Fluoro Benzaldehyde | 9456984-3 |
| LENVATINIB | 4-Chloro-7-methoxyquinoline-6-carboxamide | 417721-36-9 |
| LENVATINIB | N-(2-Chloro-4-hydroxyphenyl)-N'-cyclopropyl-urea | 796848-79-8 |
| LEVETIRACETAM | L-2-Aminobutanamide hydrochloride | 7682-20-4 |
| LEVETIRACETAM | L(+)-2-Aminobutyric acid | 1492-24-6 |
| LIFITEGRAST | 2-(Tert-butoxycarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid | 851784-82-2 |
| LIFITEGRAST | Methyl (S)-2-amino-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride | 851785-21-2 |
| LIFITEGRAST | benzofuran-6-carboxylic acid | 77095-51-3 |
| LINAGLIPTIN | (R)-3-Piperidinamine dihydrochloride | 334618-23-4 |
| LINAGLIPTIN | 2-(chloromethyl)-4-methylquinazoline | 109113-72-6 |
| LINAGLIPTIN | (R)-3-(Boc-Amino)piperidine | 309956-78-3 |
| LINAGLIPTIN | 8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione | 853029-57-9 |
| MESYLATE | 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride | 106261-49-8 |
| MIRABEGRON | 2-(4-Nitrophenyl)ethylamine hydrochloride | 29968-78-3 |
| MIRABEGRON | 2-Amino-4-thiazoleacetic acid hydrochloride | 66659-20-9 |
| MIRABEGRON | (alphaR)-alpha-[[[2-(4-Aminophenyl)ethyl]amino]methyl]benzenemethanol hydrochloride | 521284-22-0 |
| MIRABEGRON | 5-Methylisoxazole-4-(4-trifluoromethyl)carboxanilide | 75706-12-6 |
| MONTELUKAST | 2-[1-(Mercaptomethyl)cyclopropyl]acetic acid | 162515-68-6 |
| MOXIFLOXACIN | (S,S)-2,8-Diazabicyclo[4,3,0]nonane | 151213-42-2 |
| MOXIFLOXACIN | 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid | 112811-72-0 |
| MOXIFLOXACIN | 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid ethyl ester | 112811-71-9 |
| NILOTINIB | 2,3-DIMETHYL-2H-INDAZOL-6-AMINE | 444731-72-0 |
| NILOTINIB | 4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YL AMINO)-BENZOIC ACID | 641569-94-0 |
| NILOTINIB | 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline | 641571-11-1 |
| NINTEDANIB | N-(4-Aminophenyl)-N,4-dimethyl-1-piperazineacetamide | 262368-30-9 |
| NINTEDANIB | (3E)-2,3-Dihydro-3-(methoxyphenylmethylene)-2-oxo-1H-indole-6-carboxylic acid methyl este | 1168150-46-6 |
| NINTEDANIB | Methyl (3Z)-1-acetyl-3-[ethoxy(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate | 1027407-75-5 |
| NINTEDANIB | 4-(Methoxycarbonyl)-2-nitrobenzeneacetic acid methyl ester | 334952-07-7 |
| OLMESARTAN | Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5-Carboxylate | 144689-93-0 |
| OLMESARTAN | 4-Cloromethyl-5-methyl-1,3-dioxol-2-one （DMDO-CL） | 80841-78-7 |
| OLMESARTAN | 4'-Methyl-2-cyanobiphenyl | 114772-53-1 |
| OMADACYCLINE TOSYLATE | (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-N,9-bis((1,3-dioxoisoindolin-2-yl)methyl)-3,10,12,12a-tetrahydroxy- | |
| OMADACYCLINE TOSYLATE | ||
| OMADACYCLINE TOSYLATE | 1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide | 835877-67-3 |
| OMADACYCLINE TOSYLATE | (4S,4aS,5aR,12aS)-N,9-bis(aminomethyl)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6 | |
| OMADACYCLINE TOSYLATE | ,11,12a-octahydrotetracene-2-carboxamide | 835877-68-4 |
| OMADACYCLINE TOSYLATE | (4S,4aS,5aR,12aS)-9-(aminomethyl)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11, | |
| OMADACYCLINE TOSYLATE | 12a-octahydrotetracene-2-carboxamide | 488820-34-4 |
| OSELTAMAVIR | (1S,5R,6S)-Ethyl 5-(pentan-3-yl-oxy)-7-oxa-bicyclo[4.1.0]hept-3-ene-3-carboxylate | 204254-96-6 |
| OZENOXACIN | [6-[benzoyl(methyl)amino]-5-methyl-3-pyridyl]boronic acid | 446299-81-6 |
| OZENOXACIN | 5-bromo-N,3-dimethylpyridin-2-amine | 245765-66-6 |
| OZENOXACIN | ethyl 7-chloro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate | 103877-51-6 |
| PALBOCICLIB | 6-Bromo-8-cyclopentyl-2-chloro-5-Methyl-8H-pyrido[2,3-d]pyriMidin-7-one | 1016036-76-2 |
| PALBOCICLIB | tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate | 571188-59-5 |
| PAZOPANIB | 2,3-Dimethyl-2H-indazol-6-ylamine | 106649-95-0 |
| PAZOPANIB | 2,4-Dichloropyrimidine | 88046-01-9 or 3934-20-1 |
| PLERIXAFOR | 1,4,8,11-Tetraazacyclotetradecane | 295-37-4 |
| PLERIXAFOR | 1,4-Bis(bromomethyl) benzene | 623-24-5 |
| PREGABALIN | (S)-3-cyano-5-methylhexanoic acid ethyl ester | 181289-39-4 |
| PREGABALIN | R-(+)-1-phenyl-ethylamine | 3886-69-9 |
| PREGABALIN | 3-Carbamoyl methyl-5-methyl hexanoic acid | 181289-15-6 |
| PREGABALIN | (R)-(-)-3-(carbamoylmethyl)-5-methylhexanoic acid | 181289-33-8 |
| RALTEGRAVIR | 2-(1-Amino-1-methylethyl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide | 518048-03-8 |
| RALTEGRAVIR | methyl 5-hydroxy-4-oxo-2-[2-(phenylmethoxycarbonylamino)propan-2-yl]-1H-pyrimidine-6-carboxylate | 519032-08-7 |
| RALTEGRAVIR | Potassium 5-Methyl-1,3,4-oxadiazole-2-carboxylate. | 888504-28-7 |
| REMOGLIFLOZIN | 4-(4-isopropoxybenzyl)-5-methyl-1H-pyrazol-3(2H)-one | 329044-14-6 |
| REMOGLIFLOZIN | 4-(4-isopropoxybenzyl)-1-isopropyl-5-methyl-1H-pyrazol-3(2H)-one | 1028026-83-6 |
| REMOGLIFLOZIN | 2R,3R,4S,5R,6R)-2-(acetoxymethyl)-6-bromotetrahydro-2H-pyran-3,4,5-triyl triacetate | 572-09-8 |
| RIVAROXABAN | 5-Chlorothiophene-2-carboxylic acid | 24065-33-6 |
| RIVAROXABAN | 4-(4-Aminophenyl)morpholin-3-one | 438056-69-0 |
| RIVAROXABAN | 5- Chlorothiophene-2-carbonyl chloride | 42518-98-9 |
| RIVAROXABAN | 4-{4-[(5S)-5-(Aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one | 446292-10-0 |
| RIVAROXABAN | 2-[(2S)-oxiran-2-ylmethyl]-1H-isoindole-1,3(2H)-dione | 161596-47-0 |
| ROSUVASTATIN | (4R-cis)-6-Chloromethyl-2,2-dimethyl-1,3-dioxane-4-aceticAcid tert-Butyl Ester(D5) | 154026-94-5 |
| ROSUVASTATIN | tert-Butyl (4R-cis)-6-[(acetyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-acetate（D5） | 154026-95-6 |
| ROSUVASTATIN | 4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl-n-methylsulfonyl)amino]pyrimidine-5-yl-methanol（Z7) | 147118-36-3 |
| ROSUVASTATIN | Tert-Butyl 6-[(1E)-2-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]ethenyl]-2,2 | |
| RUCAPARIB | 4-Fluoro-1,3-dihydro-2H-indol-2-one | 138343-94-9 |
| RUCAPARIB | 6-Fluoro-1,3-dihydro-2H-Indol-2-one | 56341-39-0 |
| Search: | ||
| SILODOSIN | 2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate | 160969-03-9 |
| SILODOSIN | 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate | 239463-85-5 |
| SILODOSIN | 1-Acetyl-5-(2-aminopropyl)-2,3-dihydro-1H-indole-7-carbonitrile | 175837-01-1 |
| SITAGLIPTIN | 3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine HCl | 762240-92-6 |
| SITAGLIPTIN | (R)-N-Boc-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid | 486460-00-8 |
| SITAGLIPTIN | 1-ehtyl -3-(3-dimethylamino – propyl) carbodiimide | 25952-53-8 |
| SODIUM | 2-[[(3-Carboxyphenyl)amino]carbonyl]-4-mercapto-1-pyrrolidinecarboxylic acid (2S-cis)-1-[(4-nitrophenyl)methyl] ester | 202467-69-4 |
| SODIUM | 2-(2-(3s)-(3-(2-(7-chloro-2-qionolinyl)-ethenyl-phenyl)-3-hydroxy-propyl) phenyl)-2-propanol | 142569-70-8 |
| SUNITINIB | 5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid | 253870-02-9 |
| SUNITINIB | N,N-Diethylethylenediamine | 100-36-7 |
| SUNITINIB | 5-Fluorooxindole | 56341-41-4 |
| TAVABOROLE | Bis (Pinacolato)di borane | 73183-34-3 |
| TAVABOROLE | 1,1’Bis (diphenylphosphino)Ferrocene (dppf) CAS NO. | 12150-46-8 |
| TEBIPENEM | beta-Methyl vinyl phosphate | 90776-59-3 |
| TEBIPENEM | 3-Azetidinethiol, 1-(4,5-dihydro-2-thiazolyl)-, monohydrochloride | 179337-57-6 |
| TEBIPENEM | Chloromethyl Pivalate | 18997-19-8 |
| TEDIZOLID | (R)-3-(4-Bromo-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one | 444335-16-4 |
| TEDIZOLID | 2-(2-Methyl-2H-tetrazol-5-yl)pyridine-5-boronic acid pinacol ester | 1056039-83-8 |
| TEDIZOLID | (5R)-3-(4-Bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one | 444335-16-4 |
| TELMISARTAN | 4'-Bromomethyl-(1,1'-biphenyl)-2-carboxylic acid methyl ester | 114772-38-2 |
| TELMISARTAN | Methyl 4-(butyrylamino)-3-methyl-5-nitrobenzoate | 152628-01-8 |
| TELMISARTAN | 2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl) benzimidazole | 152628-02-9 |
| TELMISARTAN | Telmisartan methyl ester | 528560-93-2 |
| TEMOZOLOMIDE | 4-Nitrophenyl chloroformate | 7693-46-1 |
| TEMOZOLOMIDE | 5-amino-1-(N-methylcarbamoyl)imidazole-4-carboxamide | 188612-53-5 |
| TERBINAFINE | 1-Chloro-6,6-dimethyl-2-heptene-4-yne | 83554-69-2 |
| TERBINAFINE | N-Methyl-1-naphthalenemethylamine hydrochloride | 65473-13-4 |
| TERBINAFINE | 6,6-Dimethyl-1-hepten-4-yn-3-ol | 78629-20-6 |
| TERBINAFINE | 2E) N,6,6-Trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine | 91161-71-6 |
| TERBINAFINE | 1-Methyl-aminomethyl naphthalene | 14489-75-9 |
| TICAGRELOR | 2-[[(3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol - | |
| TICAGRELOR | (2R,3R)-2,3-dihydroxybutanedioate | 376608-65-0 |
| TICAGRELOR | (1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride | 1156491-10-9 |
| TICAGRELOR | 4,6-Dichloro-5-nitro-2-propylthiopyrimidine | 145783-14-8 |
| TICAGRELOR | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate | 376608-71-8 |
| TOFACITINIB | 4-Chloropyrrolo[2,3-d]pyrimidine | 3680-69-1 |
| TOFACITINIB | 2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine | 90213-66-4 |
| TOFACITINIB | N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine | 477600-74-1 |
| VALSARTAN | N-(2'-Cyanobiphenyl-4-ylmethyl)-L-valine Methyl Ester Hydrochloride | 482577-59-3 |
| VALSARTAN | 4-Bromomethyl-2-cyanobiphenyl | 114772-54-2 |
| VALSARTAN | L-Valine methyl ester hydrochloride | 6306-52-1 |
| VALSARTAN | 5-(4'-Bromomethyl-1,1'-biphenyl-2-yl)-1-triphenylmethyl-1H-tetrazole | 124750-51-2 |
| VILDAGLIPTIN | L-Prolinamide | 7531-52-4 |
| VILDAGLIPTIN | 3-Amino-1-Hydroxy Adamantane | 702-82-9 |
| VORICONAZOLE | 4-Chloro-6-Ethyl-5 Fluoro Pyrimidine | 137234-74-3 |
| VORICONAZOLE | 2,4-Difluoro-alpha-(1H-1,2,4-triazolyl)acetophenone | 86404-63-9 |
| VORICONAZOLE | 6-(1-Bromoethyl)-4-chloro-5-fluoropyrimidine | 188416-28-6 |
